Savvy Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32M Buy
27,696
+5,912
+27% +$6.98M 0.53% 38
2026
Q2
$26.1M Buy
21,784
+3,722
+21% +$3.8M 0.55% 34
2026
Q1
$16.6M Buy
18,062
+2,010
+13% +$2.04M 0.44% 47
2025
Q4
$17.3M Buy
16,052
+6,404
+66% +$6.12M 0.56% 37
2025
Q3
$7.36M Buy
9,648
+2,759
+40% +$2.05M 0.34% 58
2025
Q2
$5.37M Buy
6,889
+2,132
+45% +$1.66M 0.36% 51
2025
Q1
$3.93M Buy
4,757
+990
+26% +$824K 0.4% 45
2024
Q4
$2.91M Buy
3,767
+1,875
+99% +$1.55M 0.35% 51
2024
Q3
$1.68M Buy
1,892
+88
+5% +$79.1K 0.34% 61
2024
Q2
$1.63M Buy
1,804
+1,031
+133% +$825K 0.53% 42
2024
Q1
$602K Buy
773
+269
+53% +$191K 0.35% 75
2023
Q4
$294K Buy
+504
New +$294K 0.29% 111

Other funds holding LLY

Savvy Advisors's LLY Position: Q3 2026 in Review

Savvy Advisors increased its Eli Lilly (LLY) stake by 27% in Q3 2026, buying an estimated $6.98M and bringing the position to 27,696 shares worth $32M. The position accounts for 0.53% of the portfolio, ranked #38.

Savvy Advisors first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. 4,631 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Savvy Advisors held 27,696 shares of Eli Lilly worth $32M as of Q3 2026.
  • Savvy Advisors bought 5,912 Eli Lilly shares in Q3 2026, an estimated $6.98M.
  • Eli Lilly made up 0.53% of Savvy Advisors's portfolio in Q3 2026, its #38 holding.
  • Savvy Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Savvy Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.